Table 3. Demographics by outpatient and inpatient ischemic colitis groups.
Outpatient group (36 patients) | Inpatient group (29 patients) | p value | |
---|---|---|---|
Age* | 64.6±2.0 | 63.4±3.0 | 0.73 |
NSAIDs usage | 14.0% | 0% | 0.0376 |
NSAIDs and/or aspirin usage | 50% | 55.2% | 0.6781 |
Warfarin usage | 5.6% | 27.6% | 0.0144 |
Any anticoagulant usage | 8.3% | 55.2% | < 0.001 |
Anti-hypertensives usage | 16.7% | 41.4% | 0.0269 |
Hypotension or shock | 11.1% | 34.5% | 0.0227 |
Severe lung disease | 2.8% | 62.1% | < 0.001 |
Severe heart disease | 19.4% | 51.7% | 0.0122 |
Severe renal disease | 8.3% | 58.6% | 0.0001 |
Hematologic disorder+ | 52.8% | 85.7% | 0.0051 |
URBC transfusion before colonoscopy* | 1.6±1.1 | 6.7±1.7 | 0.01 |
Hospital days before urgent colonoscopy++ | 1.2±0.1 | 22.9±3.0 | 0 |
Baseline Hgb* | 11.1±0.5 | 8.9±0.5 | 0 |
Baseline PT* | 12.6±0.8 | 13.9±0.8 | 0.5 |
Baseline PTT* | 27.5±0.7 | 32.5±1.7 | 0 |
Baseline WBC* | 10.2±0.9 | 12.5±1.0 | 0.1 |
Creatinine* | 1.7±0.3 | 4.5±1.9 | 0.27 |
Prognosis score* | 1.8±0.1 | 3.3±0.2 | 0 |
Mean ± SE
Includes coagulation disorders or low platelet count
Mean hours between GI consultation and urgent colonoscopy was ≤ 12 hours